Clinical Trials Browser

Neoplasms × Dasatinib × 90 days × Clear all

NCT01445509 2026-04-06

Dasatinib in Combination With Bevacizumab to Treat Advanced Solid Tumors

Phase 1 Completed

Neoplasms

NCT04733534 2026-01-20

An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult Survivors of Childhood Cancer

Phase 2 Active not recruiting

Frailty, Neoplasms